About this Masterclass
5.5 hours of high-quality, evidence-based CPD delivered by multi-disciplinary experts
For many years it has been mooted that not all menopausal symptoms are caused by lack of oestrogen alone. Testosterone therapy in women has been proven to improve sexual desire in carefully selected patients. It is a valid treatment in those who are distressed by their lack of sexual desire where there is no other cause obvious for this. How, what, where and in whom are the challenges faced by treating clinicians. In this course, some of Australia's leading experts will discuss the evidence, describe their clinical experience and provide practical advice on how best to apply this emerging therapeutic option.
The Expert Team
Clinical leaders in women's and sexual health
-
Prof Rod Baber, Gynaecologist and Reproductive Endocrinologist
Rod is Professor of Obstetrics and Gynaecology at The University of Sydney and operates a specialist Gynaecology and Reproductive Endocrinology practice based on Sydney's lower north shore. He also heads the menopause and menstrual disorders clinic at Royal North Shore Hospital.
-
Prof Susan Davis AO, Endocrinologist
Prof Susan Davis AO is an NHMRC Senior Principal Research Fellow and Director at Monash University Women’s Health Research Program. She is also a consultant Endocrinologist and Head, Specialist Women’s Health Clinic, Alfred Hospital Melbourne. She was appointed an Officer of the Order of Australia for distinguished service to medicine, to women's health as a clinical Endocrinologist and researcher, and to medical education.
-
A/Prof John Eden, Gynaecologist
A/Prof John Eden is a Reproductive Endocrinologist and Gynaecologist. He is the Director of the Women’s Health and Research Institute of Australia, the Sydney Menopause Centre and the Barbara Gross Research Unit. His research and clinical interests include managing menopause after breast cancer, infertility, early menopause, polycystic ovary syndrome (PCOS), amenorrhoea, and hormone replacement therapy.
-
Dr Terri Foran, Sexual Health Physician
Terri is a Sexual Health Physician and holds the position of Conjoint Senior Lecturer in the School of Women’s and Children’s Health at UNSW Sydney. She has a private clinical practice in Darlinghurst and is engaged in clinical and research work at the Royal Hospital for Women in Sydney.
-
Dr Rosie King, Sexual Health Physician
Dr Rosie King has worked in general practice over 10 years before specialising in sex and relationship counselling. She is a fellow of the Royal Australasian College of Physicians in the Sexual Health Medicine Chapter and has had over 40 years of clinical experience.
Accredited with the following bodies
Course includes
Expert Panel - Testosterone for Menopausal Women - Where Can it Help?
One in three women have low libido at midlife and this problem increases with age. The topic needs to be sensitively mentioned to each older patient to discover whether the patient wants the problem actively managed. Low libido is rarely only hormonally based. The whole patient needs to be considered, including their relationship, medical and psychological conditions, medications, lifestyle, employment and stressors. Testosterone therapy, combined with topical vaginal oestrogen, has been proven to improve enjoyment of sex in female patients when they have been correctly assessed.
Testosterone for Menopausal Women - A Practical Overview
Testosterone therapy in women has been proven to improve sexual desire in carefully selected patients. It is a valid treatment in those who are distressed by their lack of sexual desire where there is no other cause obvious for this.
This presentation discusses the actions of androgens in the female body, the indications for testosterone treatment and how to appropriately investigate and manage women with hyposexual desire disorder.
Evidence and Guidelines Supporting Clinical Role of Testosterone for Women
Topical testosterone is now indicated for the treatment of postmenopausal women with low sexual desire of no obvious cause, and that is causing distress. Androgen production and metabolism in the female body is complex, and laboratory measurements of these, especially in women taking exogenous hormones, are often inaccurate. Testosterone is not indicated for any other condition in women other than low sexual desire, and when it is prescribed, close follow-up is necessary.
Management of Hypoactive Sexual Desire Dysfunction (HSDD)
Lack of sexual desire and sexual problems relating to ageing in women are common and multifactorial. Perimenopause may be associated with significant symptoms requiring treatment. Dyspareunia is under-identified and topical oestrogen for this and atrophic symptoms is under-utilised after menopause. The only evidence-based indication in Australia for testosterone therapy in women is HSDD and not for any other symptom, clinical condition or disease prevention.
Testosterone for Menopausal Women - Evidence and Application
This presentation explores the use of testosterone in the management of menopausal symptoms in women, especially with reduced libido. Despite being extensively studied for several years, only recently has there been a formal product for testosterone therapy for women available on the market. The benefit is evident, not just with regards to a woman’s sexual desire and quality of orgasms, but also on their energy levels. This lecture looks at screening for the right patient for the use of testosterone therapy and also offers practical guidance on the use of the medication, dosing and side effects.
Proudly supported by an independent educational grant from:
